Curiosis has a line of Automated Live Cell Imaging Systems called the Celloger series. Using specialized microscopes and labeling procedures, live cell imaging enables real-time observation and ...
Monjuvi shows real-world effectiveness in relapsed/refractory DLBCL, with 11.3 months PFS and 24.8 months OS. Second-line Monjuvi treatment yields higher ORR (78.5%) compared to third-line (62.8%).
CAR T-cell therapies are individualized treatments approved for multiple hematologic malignancies, with improved management of adverse effects over time. Access to CAR T-cell therapies is limited by ...
insights from industryYavuz ÇelikGlobal Product ManagerHamilton Bonaduz AG In this interview, News Medical speaks with Yavuz Çelik, Global Product Manager at Hamilton, about how real-time cell density ...
New BD FACSDiscover™ A8 Cell Analyzer Brings Leading-Edge Capabilities to Wider Range of Scientists across Academia and Biopharma FRANKLIN LAKES, N.J., May 13, 2025 /PRNewswire/ -- BD (Becton, ...
FRANKLIN LAKES, N.J., May 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the global commercial launch of the world's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results